Venus Remedies has secured the renewal of its EU-GMP certification from Infarmed, Portugal, for its Cephalosporin, Carbapenem, and Oncology...

Aurobindo, Glenmark, and Zydus are recalling pharmaceutical products in the US due to manufacturing issues. Aurobindo and Glenmark's recall...

Biocon Biologics received EMA approval to manufacture biosimilar Bevacizumab in Bengaluru, providing additional capacity to address patient...

“The idea is to bring in quality and reduce manufacturing of those drugs which are not of standard quality. A need has been felt to revisit...

Global Health is one of the largest private multi-speciality tertiary care providers operating in North and East India. It has a network of...

The company's Rs 2,206 crore IPO was sold in the range of Rs 319-336 per share and received a positive investor response. It garnered over ...

Dealers tracking the grey market said DCX Systems is a standout among all listing contenders in the near term – thanks to its pure fundamen...

Emami plans to export its healthcare portfolio under Zandu into several newer markets with the company receiving the WHO-GMP and Certificat...

Biocon on Friday said it has received the establishment inspection report (EIR) from US health regulator for the post-approval and good man...

As per the USFDA, a Form 483 is issued to Biocon's management at the conclusion of an inspection when investigator has observed any conditi...

These inspections come at a time when some of the largest Indian drug makers are still struggling with compliance procedures set by global ...

The government today said that it has not taken any decision to join the Pharmaceuticals Inspection Cooperation Scheme (PICS).

India’s drug regulator is set to restore the export certificate for Ranbaxy Laboratories’ biggest ingredient facility at Toansa in Punjab.

Domestic drug makers will no longer need a certificate of good manufacturing practice (GMP) from WHO to sell their medicines within India.

The parliamentary standing committee on health headed by Amar Singh is holding a meeting on Tuesday to assess the functioning of the three ...

Union health ministry has suspended the manufacturing licence of four leading state-owned drug makers for violating the good manufacturing ...

In what could hit the country’s vaccine exports estimated to be at Rs 1,500 crore, besides maligning the reputation of Indian companies, WH...